A recent study showed that inhibition of the mTOR pathway by rapamycin leads to the downregulation of MMP9 activity in models of Alzheimer's disease and vascular cognitive impairment 56. This evidence concerns the gene MTOR and early-onset autosomal dominant Alzheimer disease.